Category:
Active Pharmaceutical Ingredients
CAS NO:
946-99-6
Standard:
EP,
Ozagrel Sodium Impurity Ⅶ is a critical reference standard for the quality control of the antiplatelet drug Ozagrel Sodium. It is typically synthesized via oxidative coupling or specific side-reaction pathways during API manufacturing. The compound serves as an essential marker for detecting trace impurities in pharmaceutical batches.
Storage must be maintained at -20°C in a desiccated environment to prevent hydrolysis. Personnel should utilize appropriate PPE, including gloves and goggles, due to potential irritant properties. This material is strictly for laboratory use and not for clinical administration.